PUBLIC COMPANY
save$EIKNEikon Therapeutics, Inc.
$EIKN11.05+6.97%Millbrae, CA, USupdated 4h ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
- phase3A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- phase2A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
- phase2EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- phase1Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- phase3Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- phase2A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
- phase1BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab
- phase2BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Mar 2, 26grantKlobuchar Michael A · Chief Operating Officer87,157 sh
- Mar 2, 26grantHuffines Robert Luther · director25,873 sh
- Mar 2, 26grantFRAZIER KENNETH C · director25,873 sh
- Mar 2, 26grantPERLMUTTER ROGER M · See remarks268,176 sh
- Mar 2, 26grantThorner Benjamin Bruno · See Remarks67,044 sh
- Mar 2, 26grantBaynes Roy D. · Chief Medical Officer134,088 sh
🐶 Hiring Signal
Where Eikon Therapeutics, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaOncology 4
News
no news has mentioned this company yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that